Atossa Therapeutics, Inc. (ATOS) vs CervoMed Inc. (CRVO)
A side-by-side comparison of Atossa Therapeutics, Inc. and CervoMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATOS
Atossa Therapeutics, Inc.
$2.48HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
CRVO
CervoMed Inc.
$3.24HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — ATOS vs CRVO
growth of $100 · dividends reinvested · last 10yATOS -99.3% (-39.4%/yr)CRVO -100.0% (-54.0%/yr)ATOS compounded faster over this window
Log scale — wide-divergence pair
ATOS CRVO
ATOS vs CRVO: by the numbers
- •CRVO is the larger company ($30M vs $25M market cap).
- •Both run net losses; ATOS's is the smaller (0.00% vs -9408.76% net margin).
Metrics side by side
Valuation
| Metric | ATOS | CRVO |
|---|---|---|
| P/S ratio | N/A | 93.00 |
| P/B ratio | 0.92 | 1.31 |
Profitability
| Metric | ATOS | CRVO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -9408.76% |
| ROE | -140.55% | -132.18% |
| ROIC | -146.30% | -135.73% |
Growth (annualized)
| Metric | ATOS | CRVO |
|---|---|---|
| Total return CAGR (5Y) | -44.50% | -38.25% |
Frequently asked
- How have ATOS and CRVO total returns compared?
- Over the past 10 years, ATOS delivered -39.47% and CRVO delivered -53.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.